Gadolinium-Free MR Perfusion Imaging Based on Generative Adversarial Network for Primary Intracranial Tumor Diagnosis: A Multi-Center Study

Clicks: 1
ID: 318940
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #122 of 125 articles by views in journal of neuro-oncology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 125 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
BACKGROUND: Accurate evaluation of tumor vascularity is essential in neuro-oncology, but conventional cerebral blood volume (CBV) mapping depends on gadolinium-based contrast agents. The aim was to develop a gadolinium-free model to synthesize CBV (CBVsyn) maps from non-contrast MRI (NC-MRI). MATERIALS AND METHODS: This multicenter retrospective study analyzed 1227 MRI examinations in patients with primary intracranial tumors, comprising an internal cohort (train/validation/test 438/126/63) and two external cohorts (UPENN-GBM Cohort 464; UCSD-PTGBM cohort 136). A tumor-aware generative adversarial network (TA-GAN) was implemented to synthesize CBVsyn maps from various NC-MRI combinations. Image quality was evaluated using structural similarity index (SSIM), peak signal-to-noise ratio (PSNR), and a 4-point Likert scale. The correlation between pathologic markers and CBV parameters was conducted. Diagnostic performance was compared between CBVsyn and DSC-PWI-derived CBV (CBVreal) maps. The incremental diagnostic value of CBVsyn was evaluated. RESULTS: TA-GAN utilizing T2-weighted and diffusion-weighted imaging achieved best performance in CBVsyn synthesis (PSNRGlobal=25.52 ± 1.33dB, SSIMGlobal=67.53 ± 5.88; both P < .05), with 95.34% maps being diagnostically acceptable. CBVsyn parameters showed positive correlation with CD105 markers (r = 0.49, P = .03). CBVsyn maps demonstrated comparable AUC with CBVreal maps for intracranial tumors grading (0.61 vs. 0.66, P = .51), pediatric glioma (0.60 vs. 0.57; P = .57), adult glioma (0.68 vs. 0.73; P = .56), and IDH1 genotype (0.66 vs. 0.81; P = .03). NC-MRI with CBVsyn assistance improved diagnostic accuracy (84.48% vs.75.86%) and consistency (κ = 0.83 vs. 0.62) for glioma grading compared with NC-MRI alone. CONCLUSION: As a gadolinium-free alternative, CBVsyn maps synthesized by TA-GAN correlates with pathologic findings and demonstrates promise for characterizing primary intracranial tumors.
Reference Key
openalex_W7166148130 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Lin Gj, Wangbin Ding, Yihua Chen, Lukui Xiong, Junhuan Hong, Pingping He, Yuwei Pan, Minxuan Tian, Jiahao Tao, Wei Guo, Yan Su, Ming Chen, Dejun She
Journal journal of neuro-oncology
Year 2026
DOI
10.1093/neuonc/noag144
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.